XML 35 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stockholders' Equity (Tables)
3 Months Ended 5 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]    
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]
Restricted stock award activity for the period from July 22, 2016 (Inception) to March 31, 2017, including the reevaluation of the shares estimated to be release, was as follows:
 
 
 
Shares
 
Shares
Remeasured
 
Weighted-
Average
Price
 
Stock awards granted at Inception
 
 
12,209,677
 
 
 
 
 
0.20
 
Granted October 13, 2016
 
 
62,041
 
 
 
 
 
0.70
 
Granted October 16, 2016
 
 
245,434
 
 
 
 
 
0.70
 
Remeasurement at November 4, 2016
 
 
-
 
 
5,837,788
*
 
0.43
 
Vested
 
 
-
 
 
 
 
 
-
 
Reevaluation of shares expected to be released as of March 31, 2017
 
 
-
 
 
1,007,633
 
 
0.06
 
 
 
 
-
 
 
 
 
 
 
 
Unvested at March 31, 2017
 
 
12,517,152
 
 
 
 
 
0.47
 
 
 
 
 
 
 
 
 
 
 
 
Expected to vest after March 31, 2017
 
 
12,517,152
 
 
 
 
 
0
 
 
*
The number of shares Remeasured as of November 4, 2016 reflect the effect of the Monte Carlo simulation determination of the estimated number of shares expected to be released from the performance condition escrow. This estimate will be reevaluated at each quarter end until the final outcome of the performance condition is satisfied on December 31, 2017.
Restricted stock award activity for the period from July 22, 2016 (Inception) to December 31, 2016 was as follows: 
 
 
 
 
 
 
Weighted-
 
 
 
 
 
Shares
 
Average
 
 
 
Shares
 
Remeasured
 
Price
 
Stock awards granted at Inception
 
 
12,209,677
 
 
 
 
 
0.20
 
Granted October 13, 2016
 
 
62,041
 
 
 
 
 
0.70
 
Granted October 16, 2016
 
 
245,434
 
 
 
 
 
0.70
 
Remeasurement at November 4, 2016
 
 
-
 
 
5,837,788
*
 
0.43
 
Vested
 
 
-
 
 
 
 
 
-
 
Forfeited
 
 
-
 
 
 
 
 
-
 
 
 
 
-
 
 
 
 
 
 
 
Unvested at December 31, 2016
 
 
12,517,152
 
 
 
 
 
0.41
 
 
 
 
 
 
 
 
 
 
 
 
Expected to vest after December 31, 2016
 
 
12,517,152
 
 
 
 
 
0
 
 
*
The number of shares Remeasured as of November 4, 2016 reflect the effect of the Monte Carlo simulation determination of the estimated number of shares expected to be released from the performance condition escrow. This estimate will be reevaluated at each quarter end until the final outcome of the performance condition is satisfied on December 31, 2017.
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]
The fair value of stock options granted during the three months ended March 31, 2017 were estimated with the following assumptions:
 
Expected life
 
6.0 years
 
Risk-free interest rate
 
2.13
%
Expected annual volatility
 
114.20
%
Dividend yield
 
0.00
%
The fair value of stock options granted during 2016 were estimated with the following assumptions:
 
 
 
2016
 
Expected life
 
 
6.0 years
 
Risk-free interest rate
 
 
2.17
%
Expected annual volatility
 
 
113.79
%
Dividend yield
 
 
0.00
%
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
For the three months ended March 31, 2017 option activity was as follows:
 
 
 
Number of
Shares
 
Weighted
Average
Exercise Price
 
Weighted
Average
Remaining
Contractual
Life (in years)
 
Average
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1, 2017
 
 
275,137
 
 
0.48
 
 
5.15
 
 
 
 
 
 
 
 
 
 
 
 
 
.
 
 
 
 
Granted
 
 
664,000
 
 
1.17
 
 
9.88
 
 
 
 
Exercised
 
 
-
 
 
-
 
 
 
 
 
 
 
Forfeited
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at March 31, 2017
 
 
939,137
 
 
0.97
 
 
8.41
 
 
253,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vested and expected to vest at March 31. 2017
 
 
939,137
 
 
0.97
 
 
8.41
 
 
253,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at March 31, 2017
 
 
175,000
 
 
0.17
 
 
2.12
 
 
187,000
 
For the period from July 22, 2016 (Inception) to December 31, 2016 option activity was as follows:
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
 
Weighted
 
Remaining
 
Average
 
 
 
Number of
 
Average
 
Contractual
 
Intrinsic
 
 
 
Shares
 
Exercise Price
 
Life (in years)
 
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at July 22, 2016 (Inception)
 
 
-
 
 
-
 
 
-
 
 
 
 
Assumed through Recapitalization
 
 
175,000
 
 
0.17
 
 
2.38
 
 
 
 
Granted
 
 
100,137
 
 
1.02
 
 
9.99
 
 
 
 
Exercised
 
 
-
 
 
-
 
 
 
 
 
 
 
Forfeited
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at December 31, 2016
 
 
275,137
 
 
0.48
 
 
5.15
 
 
157,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vested and expected to vest at December 31, 2016
 
 
275,137
 
 
0.48
 
 
5.15
 
 
157,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at December 31, 2016
 
 
175,000
 
 
0.17
 
 
2.38
 
 
154,000
 
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]
The following table summarizes certain information about stock options for the three months ended March 31, 2017:
 
Weighted average grant-date fair value for options granted during the year
 
$
1.01
 
 
 
 
 
 
Vested options in-the-money at March 31, 2017
 
 
175,000
 
 
 
 
 
 
Aggregate intrinsic value of options exercised during the year
 
$
-
 
The following table summarizes certain information about stock options:
 
 
 
2016
 
 
 
 
 
 
Weighted average grant-date fair value for options granted during the year
 
$
0.88
 
 
 
 
 
 
Vested options in-the-money at December 31, 2016
 
 
175,000
 
 
 
 
 
 
Aggregate intrinsic value of options exercised during the year
 
$
-
 
Common Stock Shares Reserved For Future Issuance [Table Text Block]
The following table summarizes the common shares reserved for future issuance under the Plan:
 
Stock options outstanding
 
 
764,137
 
Stock options available for future grant
 
 
906,730
 
 
 
 
1,670,867
 
The following table summarizes the common shares reserved for future issuance under the Plan:
 
Stock options outstanding
 
 
100,137
 
Stock options available for future grant
 
 
1,570,730
 
 
 
 
1,670,867
 
Schedule of Other Share-based Compensation, Activity [Table Text Block]
The following table summarizes the activity in Channel Partner Warrants during the three months ended March 31, 2017:
 
 
 
Number of
Shares
 
Weighted
Average
Exercise Price
 
Weighted
Average
Remaining
Contractual
Life (in years)
 
Average
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1, 2017
 
 
350,000
 
 
1.05
 
 
4.75
 
 
 
 
Granted
 
 
1,280,000
 
 
1.11
 
 
4.82
 
 
 
 
Exercised
 
 
-
 
 
-
 
 
 
 
 
 
 
Forfeited
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at March 31, 2017
 
 
1,630,000
 
 
1.10
 
 
4.79
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vested and expected to vest at March 31, 2017
 
 
1,100,000
 
 
1.10
 
 
4.79
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at March 31, 2017
 
 
-
 
 
-
 
 
-
 
 
-
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
 
Weighted
 
Remaining
 
Average
 
 
 
Number of
 
Average
 
Contractual
 
Intrinsic
 
 
 
Shares
 
Exercise Price
 
Life (in years)
 
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at July 22, 2016 (Inception)
 
 
-
 
 
-
 
 
-
 
 
 
 
Granted
 
 
350,000
 
 
1.05
 
 
4.98
 
 
 
 
Exercised
 
 
-
 
 
-
 
 
 
 
 
 
 
Forfeited
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at December 31, 2016
 
 
350,000
 
 
1.05
 
 
4.98
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vested and expected to vest at December 31, 2016
 
 
239,000
 
 
1.05
 
 
4.98
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at December 31, 2016
 
 
-
 
 
-
 
 
-
 
 
-
 
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
The impact on our results of operations of recording stock-based compensation expense for the three months ended March 31, 2017 was as follows:
 
 
 
Restricted
 
 
 
Channel
 
Common
 
 
 
 
 
Stock at
 
Stock
 
Partner
 
Stock to
 
 
 
 
 
Inception
 
Options
 
Warrants
 
be Issued
 
Total
 
Research and development
 
 
-
 
 
-
 
 
-
 
 
-
 
 
-
 
General and administrative
 
 
270,653
 
 
15,496
 
 
-
 
 
-
 
 
286,149
 
 
 
 
270,653
 
 
15,496
 
 
-
 
 
-
 
 
286,149
 
The impact on our results of operations of recording stock-based compensation expense was as follows:
 
 
 
Restricted
 
 
 
Channel
 
Common
 
 
 
 
 
Stock at
 
Stock
 
Partner
 
Stock to
 
 
 
 
 
Inception
 
Options
 
Warrants
 
be Issued
 
Total
 
Research and development
 
 
67,842
 
 
-
 
 
-
 
 
-
 
 
67,842
 
General and administrative
 
 
1,026,135
 
 
5,542
 
 
-
 
 
6,250
 
 
1,037,927
 
 
 
 
1,093,977
 
 
5,542
 
 
-
 
 
6,250
 
 
1,105,769
 
Schedule Of Capitalized Website Development Costs [Table Text Block]  
 
 
 
Restricted
 
 
 
Stock
 
 
 
 
 
 
Capitalized website development costs
 
 
139,375